Last reviewed · How we verify

NCT03650465: CBTforGAD

Comparing Different CBT Approaches in GAD

Completed NA Last updated 15 January 2019
What this trial tests

NA trial testing Cognitive-behavioral therapy (CBT) in Generalized Anxiety Disorder in 75 participants. Completed in 30 September 2018.

Timeline
16 May 2009
Primary endpoint
30 September 2018
30 September 2018

Quick facts

Lead sponsorBabes-Bolyai University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment75
Start date16 May 2009
Primary completion30 September 2018
Estimated completion30 September 2018
Sites1 location across Romania

Drugs / interventions tested

Conditions studied

Sponsor

Babes-Bolyai University

Who can join

18 and older, any sex, with Generalized Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cognitive-behavior therapy (CBT) is considered the "golden standard" psychotherapy for generalized anxiety disorder (GAD). However, it entails different approaches and blanket statements remain hard to formulate. We conducted a randomized controlled trial to compare the most studied CBT protocol for GAD - Borkovec's treatment package - with two other forms : Rational Emotive Behavior Therapy and Acceptance and Commitment Therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cognitive-behavioral therapy (CBT)

Trials testing the same drug.

Other recruiting trials for Generalized Anxiety Disorder

Currently open trials in the same condition.

Other Babes-Bolyai University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03650465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing